Key efficacy study: -5.1% body weight, -35% fat mass, no change in appetite Lead efficacy study Mice (DIO) C57BL/6, 60% kcal-from-fat diet, 20 mg/kg x3/day subcutaneous, 11 days, n=9-10/group Neelakantan et al
This milestone makes semaglutide the only oral GLP-1 RA with proven blood glucose and body weight reduction, as well as cardiovascular benefits. New results from the SOUL trial will be shared later this week at the European Association for the Study of Diabetes e.V
So friends, thank you so much for being here with us over all the years, and especially this past year that Barry has been here
For the most up-to-date list, please refer to the product packaging
6 8 With age and chronic stress, brain GSH levels decline, leaving the brain more vulnerable to oxidative damage, inflammation, brain fog, and mental fatigue
Call us today at (703) 870-3750 to schedule your consultation